C07D 513/04
Ortho-condensed systems
C07D513/04 (Ortho-condensed systems) appears on 4,171 US grants and 4,427 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,171
- Published applications
- 4,427
- Assignees
- 1,557
- Inventors
- 13,707
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 30 | 0 |
| 1978 | 41 | 0 |
| 1979 | 42 | 0 |
| 1980 | 32 | 0 |
| 1981 | 40 | 0 |
| 1982 | 38 | 0 |
| 1983 | 27 | 0 |
| 1984 | 40 | 0 |
| 1985 | 48 | 0 |
| 1986 | 40 | 0 |
| 1987 | 35 | 0 |
| 1988 | 51 | 0 |
| 1989 | 52 | 0 |
| 1990 | 46 | 0 |
| 1991 | 48 | 0 |
| 1992 | 45 | 0 |
| 1993 | 52 | 0 |
| 1994 | 41 | 0 |
| 1995 | 54 | 0 |
| 1996 | 73 | 0 |
| 1997 | 101 | 0 |
| 1998 | 74 | 0 |
| 1999 | 47 | 0 |
| 2000 | 43 | 0 |
| 2001 | 55 | 15 |
| 2002 | 59 | 61 |
| 2003 | 74 | 111 |
| 2004 | 57 | 148 |
| 2005 | 53 | 150 |
| 2006 | 65 | 148 |
| 2007 | 82 | 162 |
| 2008 | 74 | 137 |
| 2009 | 92 | 189 |
| 2010 | 142 | 211 |
| 2011 | 123 | 208 |
| 2012 | 169 | 186 |
| 2013 | 151 | 174 |
| 2014 | 181 | 233 |
| 2015 | 200 | 214 |
| 2016 | 155 | 175 |
| 2017 | 178 | 176 |
| 2018 | 149 | 195 |
| 2019 | 149 | 204 |
| 2020 | 143 | 216 |
| 2021 | 140 | 172 |
| 2022 | 106 | 176 |
| 2023 | 116 | 218 |
| 2024 | 110 | 236 |
| 2025 | 106 | 185 |
| 2026 | 70 | 127 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Rock inhibitor and preparation method therefor and use thereof15 Sep 2026US 12,735,414 B2Wuhan Ll Science and Technology Development Co., Ltd.
- Inhibitor of apoptosis (IAP) protein antagonists8 Sep 2026US 12,729,208 B2Sanford Burnham Prebys Medical Discovery Institute
- Aryltetrahydropyridazine derivative or salt thereof, insecticidal agent containing the compound, and method of use thereof1 Sep 2026US 12,723,036 B2Nihon Nohyaku Co., Ltd.
- Compounds useful as immunomodulators25 Aug 2026US 12,715,856 B2Bristol-Myers Squibb Company
- Voltage sensitive thiazolothiazole dyes and associated synthetic methods8 Oct 2026US 2026/0308176 A1
- Thiazolopyridin-7(4h)-one wrn inhibitors8 Oct 2026US 2026/0308177 A1Nimbus Wadjet, Inc.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Bicyclic compounds as cdk inhibitors1 Oct 2026US 2026/0297080 A1BeOne Medicines I GmbH
Most cited
By later US patents
- Precursor to nucleic acid probe282US 4,754,065 ACetus Corporation · 1988
- Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof270US 6,110,929 A3M Innovative Properties Company · 2000
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents219US 5,552,422 AMerck Frosst Canada, Inc. · 1996
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003